SXI Life Sciences
7.772,36
PKT
-3,32
PKT
-0,04
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 11.07.17 | Roche overweight | JP Morgan Chase & Co. | |
| 11.07.17 | Roche neutral | Kepler Cheuvreux | |
| 10.07.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 07.07.17 | Novartis Hold | Deutsche Bank AG | |
| 07.07.17 | Roche Hold | Deutsche Bank AG | |
| 06.07.17 | Roche Neutral | UBS AG | |
| 05.07.17 | Roche buy | Citigroup Corp. | |
| 05.07.17 | Novartis Underperform | Credit Suisse Group | |
| 04.07.17 | Novartis buy | Kepler Cheuvreux | |
| 30.06.17 | Roche overweight | JP Morgan Chase & Co. | |
| 29.06.17 | Roche Hold | Société Générale Group S.A. (SG) | |
| 27.06.17 | Roche buy | Deutsche Bank AG | |
| 27.06.17 | Roche overweight | JP Morgan Chase & Co. | |
| 27.06.17 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
| 23.06.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 23.06.17 | Novartis Equal weight | Barclays Capital | |
| 23.06.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 23.06.17 | Novartis buy | Jefferies & Company Inc. | |
| 21.06.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 21.06.17 | Novartis Hold | Deutsche Bank AG | |
| 21.06.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 21.06.17 | Novartis buy | HSBC | |
| 20.06.17 | Roche Neutral | BNP PARIBAS | |
| 19.06.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 16.06.17 | Roche buy | Jefferies & Company Inc. | |
| 16.06.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 15.06.17 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
| 14.06.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 13.06.17 | Roche overweight | Barclays Capital | |
| 08.06.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 07.06.17 | Roche overweight | JP Morgan Chase & Co. | |
| 06.06.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 06.06.17 | Novartis Underweight | Morgan Stanley | |
| 06.06.17 | Roche buy | Deutsche Bank AG | |
| 06.06.17 | Roche Hold | Kepler Cheuvreux | |
| 06.06.17 | Roche Reduce | HSBC | |
| 02.06.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 02.06.17 | Novartis Underweight | Barclays Capital | |
| 02.06.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 01.06.17 | Novartis buy | Jefferies & Company Inc. |